カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の髄膜炎菌ワクチン市場2023-2030：ブランド別（Menactra、Menveo）、種類別、血清型別、年齢層別、販売チャネル別、地域別

【英語タイトル】Meningococcal Vaccines Market Size, Share & Trends Analysis Report By Brand (Menactra, Menveo), By Type, By Serotype, By Age Group, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN071）・商品コード：GRV23JUN071
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月11日
・ページ数：163
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界の髄膜炎菌ワクチン市場規模が、予測期間中に年平均6.0％増加し、2030年までに52.8億ドルへ達すると見込まれています。本調査書では、髄膜炎菌ワクチンの世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、種類別（2価、4価、その他）分析、ブランド別（Menactra、Menveo、Nimenrix、Trumenba、その他）分析、年齢層別（幼児（0-2歳）、小児・成人（2歳以上））分析、血清型別（血清型A、血清型B、血清型C、血清型W-113、血清型Y）分析、地域別（北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ）分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、Sanofi、Merck & Co., Inc.、Gsk Plc、Serum Institute Of India Pvt. Ltd.、Pfizer, Inc.、Walwax Biotechnology Co., Ltd、Petrovaxなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界髄膜炎菌ワクチンの市場規模：種類別
- 2価髄膜炎菌ワクチンの市場規模
- 4価髄膜炎菌ワクチンの市場規模
- その他髄膜炎菌ワクチンの市場規模
・世界髄膜炎菌ワクチンの市場規模：ブランド別
- Menactraの市場規模
- Menveoの市場規模
- Nimenrixの市場規模
- Trumenbaの市場規模
- その他ブランドの市場規模
・世界髄膜炎菌ワクチンの市場規模：年齢層別
- 幼児（0-2歳）における市場規模
- 小児・成人（2歳以上）における市場規模
・世界髄膜炎菌ワクチンの市場規模：血清型別
- 血清型Aにおける市場規模
- 血清型Bにおける市場規模
- 血清型Cにおける市場規模
- 血清型W-113における市場規模
- 血清型Yにおける市場規模
・世界髄膜炎菌ワクチンの市場規模：地域別
- 北米の髄膜炎菌ワクチン市場規模
- ヨーロッパの髄膜炎菌ワクチン市場規模
- アジア太平洋の髄膜炎菌ワクチン市場規模
- 中南米の髄膜炎菌ワクチン市場規模
- 中東・アフリカの髄膜炎菌ワクチン市場規模
・競争状況

髄膜炎菌ワクチン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、髄膜炎菌ワクチンの世界市場規模は2030年までに52.8億米ドルに達し、予測期間中のCAGRは6.0%を記録すると予測されています。髄膜炎の有病率の増加は、市場成長の主な要因の一つです。例えば、ECDCによると、2017年にはEU加盟国で3,221件の確定症例が観察され、58％の症例が英国、フランス、スペイン、ドイツで見つかったと推定されています。さらに、髄膜炎疾患の高い発生率はサハラ以南のアフリカの「髄膜炎ベルト」に見られ、この地域では毎年約3万件の症例が報告されています。

さらに、髄膜炎菌ワクチンに対するFDA認可の高まりが成長を後押しすると予想されます。例えば、2020年4月、Sanofi社はメンクアッドフィ髄膜炎菌結合型ワクチンについて、2歳以上の侵襲性髄膜炎菌障害の予防を適応とするFDAの承認を取得しました。新規ワクチンの承認の増加は、髄膜炎菌予防の改善につながり、ひいては市場を牽引すると予想されます。

髄膜炎菌ワクチンの市場成長を後押しするのは、髄膜炎菌疾患の発生率上昇に対抗するために政府が実施する取り組みであると予想されます。例えば、2019年4月より、オーストラリアでは15歳から19歳を対象とした全国予防接種プログラム（NIP）の一環として、ニメンリックスが無料で接種できるようになりました。ニメンリックスは、血清群A、C、W、Yを標的とする4価髄膜炎菌ワクチンです。

WHOによると、2021年現在、髄膜炎ベルトに属する26カ国のうち24カ国が、1歳から29歳を対象とした集団予防キャンペーンを導入しています。さらに、約13カ国が国の定期予防接種プログラムにワクチンを組み込んでいます。このような疾病負担の大きい国々によるイニシアチブは、市場の成長を後押しすると期待されています。

弱い立場にある子どもたちのための新しいワクチンへの接近を改善するために、提携や連携などの戦略的イニシアティブに参入する非営利団体は、市場を牽引すると予想されます。例えば、2021年9月、WHOとそのパートナーは、髄膜炎を撲滅する史上初の世界戦略を発表しました。このイニシアチブは、細菌性髄膜炎の流行を減らすことを目的としています。この戦略の下、WHOは年間20万人以上の命を救うことを目標としています。

髄膜炎菌性疾患の有病率が増加している国々では、ワクチンが低価格で入手可能であるため、製造業者の収益が増加し、髄膜炎菌ワクチン市場を牽引すると予想されます。例えば、髄膜炎ワクチンプロジェクトの下ではMenAfriVacのコストは1回あたり0.5米ドル未満です。

髄膜炎菌ワクチン市場レポートハイライト

– 4価ワクチンは、4つの血清群を標的とする能力があり、Menveo、Menactra、Nimenrixなどのワクチンの存在感が強いため、2022年のタイプ別売上シェアは51.1%と最も大きくなっています。

– 乳幼児（0～2歳）セグメントは、予測期間中最も急成長することが予想されます。生後9ヵ月から11歳までの髄膜炎有病率の増加が、このセグメントの成長に寄与しています。

– アジア太平洋地域は予測期間中最も高いCAGRが見込まれます。アンメットニーズの高さ、医療費の増加、人口基盤の大きさなどが、同地域の市場を強化する可能性が高いです。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Meningococcal Vaccines Market Variables, Trends, And Scope
3.1 Penetration And Growth Prospect Mapping
3.2 Product Pipeline Analysis
3.3 Regulatory Framework
3.3.1 North America
3.3.2 Europe
3.3.3 Asia Pacific
3.3.4 Latin America
3.3.5 Middle East & Africa
3.4 Market Driver Analysis
3.4.1 Rising Incidence Of Meningitis
3.4.2 Rising R&D In Meningococcal Vaccines
3.4.3 Increasing Immunization Programs And Government Initiatives
3.4.4 Growing Support By Healthcare Services In Providing Low-Cost Meningococcal Vaccine
3.5 Market Restraint Analysis
3.5.1 High Cost Associated With Storage And Supply Of Vaccines
3.5.2 Challenges Associated With Vaccine Development
3.6 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.7 Porter’s Five Forces Analysis
3.8 Major Deals And Strategic Alliances Analysis
3.8.1 New Product Launches
3.8.2 Mergers And Acquisitions
3.8.3 Expansion
3.8.4 Partnerships
3.8.5 Marketing And Promotions
3.8.6 Market Entry Strategies
Chapter 4 Meningococcal Vaccines Market: Segment Analysis, By Type, 2018 – 2030 (USD Million)
4.1 Definition And Scope
4.2 Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Meningococcal Vaccines Market, By Type, 2018 To 2030
4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
4.5.1 Bivalent
4.5.1.1 Bivalent Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.5.2 Quadrivalent
4.5.2.1 Quadrivalent Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.5.3 Others
4.5.3.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Meningococcal Vaccines Market: Segment Analysis, By Brand, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.1 Definition And Scope
5.2 Brand Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Meningococcal Vaccines Market, By Brand, 2018 To 2030
5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
5.5.1 Menactra
5.5.1.1 Menactra Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.2 Menveo
5.5.2.1 Menveo Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.3 Nimenrix
5.5.3.1 Nimenrix Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.4 Trumenba
5.5.4.1 Trumenba Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.5 Bexsero
5.5.5.1 Bexsero Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.6 Others
5.5.6.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
Chapter 6 Meningococcal Vaccines Market: Segment Analysis, By Age Group, 2018 – 2030 (USD Million)
6.1 Definition And Scope
6.2 Age Group Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Meningococcal Vaccines Market, By Age Group, 2018 To 2030
6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
6.5.1 Infants (0-2 Years)
6.5.1.1 Infants Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.5.2 Children And Adults (2 Years And Above)
6.5.2.1 Children And Adults Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Meningococcal Vaccines Market: Segment Analysis, By Serotype, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.1 Definition And Scope
7.2 Serotype Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Meningococcal Vaccines Market, By Serotype, 2018 To 2030
7.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
7.5.1 Serotype A
7.5.1.1 Serotype A Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.5.2 Serotype B
7.5.2.1 Serotype B Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.5.3 Serotype C
7.5.3.1 Serotype C Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.5.4 Serotype W-135
7.5.4.1 Serotype W Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.5.5 Serotype Y
7.5.5.1 Serotype Y Market Estimates And Forecast, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
Chapter 8 Meningococcal Vaccines Market: Segment Analysis, By Sales Channel, 2018 – 2030 (USD Million)
8.1 Definition And Scope
8.2 Sales Channel Market Share Analysis, 2022 & 2030
8.3 Segment Dashboard
8.4 Global Meningococcal Vaccines Market, By Sales Channel, 2018 To 2030
8.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
8.5.1 Private
8.5.1.1 Private Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.2 Public
8.5.2.1 Public Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 9 Meningococcal Vaccines Market: Segment Analysis, By Region, 2018 – 2030 (USD Million)
9.1 Definition & Scope
9.2 Regional Market Share Analysis, 2022 & 2030
9.3 Regional Market Dashboard
9.4 Regional Market Snapshot
9.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
9.5.1 North America
9.5.1.1 North America Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.1.2 U.S.
9.5.1.2.1 Key Country Dynamics
9.5.1.2.2 Competitive Scenario
9.5.1.2.3 Regulatory Framework
9.5.1.2.4 Reimbursement Scenario
9.5.1.2.5 U.S. Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.1.3 Canada
9.5.1.3.1 Key Country Dynamics
9.5.1.3.2 Competitive Scenario
9.5.1.3.3 Regulatory Framework
9.5.1.3.4 Reimbursement Scenario
9.5.1.3.5 Canada Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2 Europe
9.5.2.1 Europe Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.2 Germany
9.5.2.2.1 Key Country Dynamics
9.5.2.2.2 Competitive Scenario
9.5.2.2.3 Regulatory Framework
9.5.2.2.4 Reimbursement Scenario
9.5.2.2.5 Germany Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.3 Uk
9.5.2.3.1 Key Country Dynamics
9.5.2.3.2 Competitive Scenario
9.5.2.3.3 Regulatory Framework
9.5.2.3.4 Reimbursement Scenario
9.5.2.3.5 Uk Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.4 France
9.5.2.4.1 Key Country Dynamics
9.5.2.4.2 Competitive Scenario
9.5.2.4.3 Regulatory Framework
9.5.2.4.4 Reimbursement Scenario
9.5.2.4.5 France Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.5 Spain
9.5.2.5.1 Key Country Dynamics
9.5.2.5.2 Competitive Scenario
9.5.2.5.3 Regulatory Framework
9.5.2.5.4 Reimbursement Scenario
9.5.2.5.5 Spain Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.6 Italy
9.5.2.6.1 Key Country Dynamics
9.5.2.6.2 Competitive Scenario
9.5.2.6.3 Regulatory Framework
9.5.2.6.4 Reimbursement Scenario
9.5.2.6.5 Italy Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.7 Russia
9.5.2.7.1 Key Country Dynamics
9.5.2.7.2 Competitive Scenario
9.5.2.7.3 Regulatory Framework
9.5.2.7.4 Reimbursement Scenario
9.5.2.7.5 Russia Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.8 Belarus
9.5.2.8.1 Key Country Dynamics
9.5.2.8.2 Competitive Scenario
9.5.2.8.3 Regulatory Framework
9.5.2.8.4 Reimbursement Scenario
9.5.2.8.5 Belarus Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.9 Georgia
9.5.2.9.1 Key Country Dynamics
9.5.2.9.2 Competitive Scenario
9.5.2.9.3 Regulatory Framework
9.5.2.9.4 Reimbursement Scenario
9.5.2.9.5 Georgia Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.10 Moldova
9.5.2.10.1 Key Country Dynamics
9.5.2.10.2 Competitive Scenario
9.5.2.10.3 Regulatory Framework
9.5.2.10.4 Reimbursement Scenario
9.5.2.10.5 Moldova Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.11 Denmark
9.5.2.11.1 Key Country Dynamics
9.5.2.11.2 Competitive Scenario
9.5.2.11.3 Regulatory Framework
9.5.2.11.4 Reimbursement Scenario
9.5.2.11.5 Denmark Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.12 Sweden
9.5.2.12.1 Key Country Dynamics
9.5.2.12.2 Competitive Scenario
9.5.2.12.3 Regulatory Framework
9.5.2.12.4 Reimbursement Scenario
9.5.2.12.5 Sweden Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.13 Norway
9.5.2.13.1 Key Country Dynamics
9.5.2.13.2 Competitive Scenario
9.5.2.13.3 Regulatory Framework
9.5.2.13.4 Reimbursement Scenario
9.5.2.13.5 Norway Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.3 Asia Pacific
9.5.3.1 Asia Pacific Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.3.2 Japan
9.5.3.2.1 Key Country Dynamics
9.5.3.2.2 Competitive Scenario
9.5.3.2.3 Regulatory Framework
9.5.3.2.4 Reimbursement Scenario
9.5.3.2.5 Japan Market Estimate And Forecasts, 2018 – 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.3.3 China
9.5.3.3.1 Key Country Dynamics
9.5.3.3.2 Competitive Scenario
9.5.3.3.3 Regulatory Framework
9.5.3.3.4 Reimbursement Scenario

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Product Pipeline
Table 4 CDC Vaccine Price List
Table 5 List of Key Emerging Companies /Technology Disruptors/Innovators
Table 6 North America Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 7 North America Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 8 North America Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 9 North America Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 10 North America Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 11 North America Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 13 U.S. Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 14 U.S. Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 15 U.S. Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 16 U.S. Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 17 Canada Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 18 Canada Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 19 Canada Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 20 Canada Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 21 Canada Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 22 Europe Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 23 Europe Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 24 Europe Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 25 Europe Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 26 Europe Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 27 Europe Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 28 Germany Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 29 Germany Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 30 Germany Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 31 Germany Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 32 Germany Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 33 UK Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 34 UK Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 35 UK Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 36 UK Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 37 UK Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 38 France Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 39 France Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 40 France Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 41 France Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 42 France Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 43 Italy Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 44 Italy Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 45 Italy Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 46 Italy Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 47 Italy Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 48 Spain Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 49 Spain Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 50 Spain Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 51 Spain Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 52 Spain Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 53 Russia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 54 Russia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 55 Russia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 56 Russia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 57 Russia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 58 Belarus Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 59 Belarus Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 60 Belarus Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 61 Belarus Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 62 Belarus Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 63 Georgia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 64 Georgia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 65 Georgia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 66 Georgia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 67 Georgia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 68 Moldova Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 69 Moldova Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 70 Moldova Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 71 Moldova Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 72 Moldova Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 73 Denmark Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 74 Denmark Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 75 Denmark Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 76 Denmark Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 77 Denmark Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 78 Sweden Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 79 Sweden Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 80 Sweden Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 81 Sweden Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 82 Sweden Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 83 Norway Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 84 Norway Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 85 Norway Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 86 Norway Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 87 Norway Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 88 Asia Pacific Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 89 Asia Pacific Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 90 Asia Pacific Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 91 Asia Pacific Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 92 Asia Pacific Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 93 Asia Pacific Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 94 Japan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 95 Japan Meningococcal Vaccines Market, By Brand 2018 - 2030 (USD Million)
Table 96 Japan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 97 Japan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 98 Japan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 99 China Meningococcal Vaccines Market, By Product, 2018 - 2030 (USD Million)
Table 100 China Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 101 China Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 102 China Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 103 China Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 104 India Meningococcal Vaccines Market, By Product, 2018 - 2030 (USD Million)
Table 105 India Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 106 India Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 107 India Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 108 India Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 109 Australia Meningococcal Vaccines Market, By Product, 2018 - 2030 (USD Million)
Table 110 Australia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 111 Australia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 112 Australia Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 113 Australia Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 114 Singapore Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 115 Singapore Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 116 Singapore Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 117 Singapore Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 118 Singapore Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 119 South Korea Meningococcal Vaccines Market, By Type 2018 - 2030 (USD Million)
Table 120 South Korea Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 121 South Korea Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 122 South Korea Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 123 South Korea Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 124 Thailand Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 125 Thailand Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 126 Thailand Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 127 Thailand Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 128 Thailand Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 129 Vietnam Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 130 Vietnam Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 131 Vietnam Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 132 Vietnam Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 133 Vietnam Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 134 Malaysia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 135 Malaysia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 136 Malaysia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 137 Malaysia Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 138 Malaysia Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 139 Indonesia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 140 Indonesia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 141 Indonesia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 142 Indonesia Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 143 Indonesia Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 144 Kazakhstan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 145 Kazakhstan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 146 Kazakhstan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 147 Kazakhstan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 148 Kazakhstan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 149 Kyrgyzstan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 150 Kyrgyzstan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 151 Kyrgyzstan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 152 Kyrgyzstan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 153 Kyrgyzstan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 154 Armenia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 155 Armenia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 156 Armenia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 157 Armenia Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 158 Armenia Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 159 Azerbaijan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 160 Azerbaijan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 161 Azerbaijan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 162 Azerbaijan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 163 Azerbaijan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 164 Tajikistan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 165 Tajikistan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 166 Tajikistan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 167 Tajikistan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 168 Tajikistan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 169 Turkmenistan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 170 Turkmenistan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 171 Turkmenistan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 172 Turkmenistan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 173 Turkmenistan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 174 Uzbekistan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 175 Uzbekistan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 176 Uzbekistan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 177 Uzbekistan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 178 Uzbekistan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 179 Latin America Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 180 Latin America Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 181 Latin America Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 182 Latin America Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 183 Latin America Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 184 Latin America Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 185 Brazil Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 186 Brazil Meningococcal Vaccines Market, By Brand 2018 - 2030 (USD Million)
Table 187 Brazil Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 188 Brazil Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 189 Brazil Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 190 Mexico Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 191 Mexico Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 192 Mexico Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 193 Mexico Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 194 Mexico Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 195 Argentina Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 196 Argentina Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 197 Argentina Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 198 Argentina Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 199 Argentina Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 200 Chile Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 201 Chile Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 202 Chile Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 203 Chile Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 204 Chile Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 205 Cuba Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 206 Cuba Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 207 Cuba Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 208 Cuba Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 209 Cuba Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 210 Ecuador Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 211 Ecuador Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 212 Ecuador Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 213 Ecuador Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 214 Ecuador Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 215 Peru Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 216 Peru Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 217 Peru Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 218 Peru Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 219 Peru Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 220 Colombia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 221 Colombia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 222 Colombia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 223 Colombia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 224 Colombia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 225 Venezuela Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 226 Venezuela Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 227 Venezuela Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 228 Venezuela Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 229 Venezuela Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 230 Middle East & Africa Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 231 Middle East & Africa Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 232 Middle East & Africa Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 233 Middle East & Africa Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 234 Middle East & Africa Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 235 Middle East & Africa Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 236 Saudi Arabia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 237 Saudi Arabia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 238 Saudi Arabia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 239 Saudi Arabia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 240 Saudi Arabia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 241 South Africa Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 242 South Africa Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 243 South Africa Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 244 South Africa Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 245 South Africa Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 246 UAE Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 247 UAE Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 248 UAE Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 249 UAE Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 250 UAE Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 251 Algeria Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 252 Algeria Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 253 Algeria Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 254 Algeria Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 255 Algeria Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 256 Egypt Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 257 Egypt Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 258 Egypt Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 259 Egypt Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 260 Egypt Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 261 Tunisia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 262 Tunisia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 263 Tunisia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 264 Tunisia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 265 Tunisia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 266 Iran Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 267 Iran Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 268 Iran Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 269 Iran Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 270 Iran Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 271 Turkey Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 272 Turkey Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 273 Turkey Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 274 Turkey Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 275 Turkey Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 276 Iraq Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 277 Iraq Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 278 Iraq Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 279 Iraq Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 280 Iraq Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 281 Morocco Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 282 Morocco Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 283 Morocco Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 284 Morocco Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 285 Morocco Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 286 Kuwait Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 287 Kuwait Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 288 Kuwait Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 289 Kuwait Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 290 Kuwait Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)

★調査レポート[世界の髄膜炎菌ワクチン市場2023-2030：ブランド別（Menactra、Menveo）、種類別、血清型別、年齢層別、販売チャネル別、地域別] (コード：GRV23JUN071)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の髄膜炎菌ワクチン市場2023-2030：ブランド別（Menactra、Menveo）、種類別、血清型別、年齢層別、販売チャネル別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のインフルエンザワクチン市場2024-2030：ワクチン種類別（不活化、弱毒化）、疾患別、年齢層別、投与経路別、販売チャネル別、地域別
  • 世界の経腸栄養剤市場2023-2030：製品別、フロー種類別、年齢層別、疾患別、エンドユーザー別、販売チャネル別、地域別
  • 世界の女性用健康・美容サプリメント市場2023-2030：製品別、用途別、年齢層別、消費者層別、販売チャネル別、地域別
  • 世界の医薬品製造市場2023-2030：投与経路別、分子種類別、医薬品開発種類別、販売チャネル別、年齢層別、製剤別、地域別
  • 世界の生体吸収性冠動脈ステント市場2023-2030：ブランド別（Magmaris、Magnitude、MeRes-100、DESolve、その他）、地域別
  • 世界の人工内耳市場2024-2030：年齢層別（成人、小児）、エンドユーザー別（病院、クリニック）、地域別
  • 世界の人工尿道括約筋市場2023-2030：ブランド別（AMS 800、その他）、エンドユーザー別（男性、女性）、地域別（北米、アジア太平洋、ヨーロッパ、中南米）
  • 世界の女性化乳房手術市場2023-2030：年齢層別（18～40歳、40歳以上）、手術種類別（脂肪吸引、切除）、最終用途別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆